EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Precise gene editing of pathogenic Lamin A mutations corrects cardiac disease

Xurde M Caravia, Brian Hayashi iD, Hui Li iD, Peiheng Gan, Damir Alzhanov, Wei Tan, Kenian Chen, John R McAnally, Lin Xu, Ning Liu, Eric N Olson iD

Proceedings of the National Academy of Sciences · 28.10.2025 · 122 (43)

DOI: 10.1073/pnas.2515267122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 13.10.2025. Verfasst von Xurde M Caravia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 7539…. Hauptthemen laut MEDLINE: Lamin Type A, Gene Editing, Mutation, Cardiomyopathy, Dilated. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), the British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in the Lamin A ( LMNA ) gene, which encodes the Lamin A and C proteins, cause severe human diseases collectively known as laminopathies. These conditions are often devastating and lack effective therapies. In this study, we developed precise base editing (BE) strategies targeting the human LMNA gene variants L35P and R249Q, which cause congenital muscular dystrophy (CMD) and dilated cardiomyopathy with conduction defects (DCM-CD), respectively. Induced pluripotent stem cell–derived cardiomyocytes (iPSC-CMs) carrying the R249Q mutation displayed nuclear aberrations, DNA damage, and abnormal Ca 2+ transients. Similarly, L35P iPSC-CMs exhibited abnormal contraction, DNA damage, and reduced Lamin A/C protein expression. We also generated “humanized” mouse models carrying these pathogenic human mutations. R249Q homozygous mice exhibited cardiac conduction abnormalities, cardiac arrhythmias, and premature death. Mice with the homozygous L35P mutation displayed severe muscle-wasting and reduced lifespan, while heterozygous L35P mice displayed DCM. We developed an adenine base editing (ABE) approach for correcting the R249Q mutation and a cytosine base editing (CBE) strategy for the L35P variant. Precise correction of these mutations in iPSC-CMs successfully rescued all of the in vitro abnormalities. Furthermore, delivery of the BE components using adeno-associated virus prevented the pathological phenotypes and extended longevity of mice carrying the LMNA L35P and the R249Q mutations. These results demonstrate the efficacy of ABE and CBE in correcting pathogenic LMNA mutations that cause cardiac disease, highlighting BE as a promising therapeutic approach for human laminopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lamin Type AGene EditingMutationCardiomyopathy, DilatedAnimalsMiceHumansMyocytes, CardiacInduced Pluripotent Stem CellsDisease Models, AnimalMuscular Dystrophies

Stichwörter der Autor:innen

LMNAcardiomyopathygene editing

Substanzen

Lamin Type ALMNA protein, human

Autor:innen und Institutionen

  • Department of Molecular Biology, Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390.

ORCID-Profile: Brian Hayashi, Hui Li, Eric N Olson

Förderung

  • HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  • HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
  • the British Heart Foundation
  • NIDDK NIH HHS
  • The Leducq Foundation Transatlantic Networks of Excellence
  • NHLBI NIH HHS
  • NICHD NIH HHS
  • The Robert A. Welch Foundation

Zitieren

APA

Caravia, X. M., Hayashi, B., Li, H., Gan, P., Alzhanov, D., Tan, W., Chen, K., McAnally, J. R., Xu, L., Liu, N., & Olson, E. N. (2025). Precise gene editing of pathogenic Lamin A mutations corrects cardiac disease. Proceedings of the National Academy of Sciences, 122(43). https://doi.org/10.1073/pnas.2515267122

Vancouver

Caravia XM, Hayashi B, Li H, Gan P, Alzhanov D, Tan W, et al. Precise gene editing of pathogenic Lamin A mutations corrects cardiac disease. Proceedings of the National Academy of Sciences. 2025;122(43). doi:10.1073/pnas.2515267122

BibTeX
@article{Caravia2025,
  author = {Caravia, Xurde M and Hayashi, Brian and Li, Hui and Gan, Peiheng and Alzhanov, Damir and Tan, Wei and Chen, Kenian and McAnally, John R and Xu, Lin and Liu, Ning and Olson, Eric N},
  title = {Precise gene editing of pathogenic Lamin A mutations corrects cardiac disease},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {43},
  doi = {10.1073/pnas.2515267122}
}
Kostenlos starten →